Literature DB >> 8905446

Quadriparesia following permissive hypercapnia and inhalational anesthesia in a patient with severe status asthmaticus.

H O Zender, P Eggimann, P Bulpa, J C Chevrolet, P Jolliet.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8905446     DOI: 10.1007/bf02044136

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Permissive hypercapnia. How permissive should we be?

Authors:  F Feihl; C Perret
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

2.  Treatment of acute severe asthma assisted by hypothermia.

Authors:  D Browning; D T Goodrum
Journal:  Anaesthesia       Date:  1992-03       Impact factor: 6.955

3.  Transient neuromuscular impairment resulting from prolonged inhalation of halothane and enflurane.

Authors:  T Tanigaki; T Kondo; Y Ohta; H Yamabayashi
Journal:  Chest       Date:  1990-10       Impact factor: 9.410

4.  Reversible sensorimotor impairment following prolonged ventilation with isoflurane and vecuronium for acute severe asthma.

Authors:  H du Peloux Menagé; S Duffy; D W Yates; J A Hughes
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

5.  Local application of 133Xenon for measurement of regional cerebral blood flow (rCBF) during halothane, enflurane, and isoflurane anesthesia in humans.

Authors:  C Eintrei; W Leszniewski; C Carlsson
Journal:  Anesthesiology       Date:  1985-10       Impact factor: 7.892

  5 in total
  2 in total

1.  Experience with use of extracorporeal life support for severe refractory status asthmaticus in children.

Authors:  Kiran B Hebbar; Toni Petrillo-Albarano; Wendy Coto-Puckett; Micheal Heard; Peter T Rycus; James D Fortenberry
Journal:  Crit Care       Date:  2009-03-02       Impact factor: 9.097

Review 2.  Hypercapnia: An Aggravating Factor in Asthma.

Authors:  Masahiko Shigemura; Tetsuya Homma; Jacob I Sznajder
Journal:  J Clin Med       Date:  2020-10-05       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.